← Leaderboards
C.k. Osborne
Leidos Biomedical Research, Inc.
$3,516,733
Attributed
$3,516,733
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2022–24$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
Funding mix
By agency
NIH$3,516,733 · 1
By mechanism
N01$3,516,733 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- Christine Siemon$684,372
Others in their field
Other Rising Stars on “Adverse Event”
- Lauren Miller · Technical Resources International, Inc.$31,120,905
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,688,224
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
Adverse EventAdultAntibodiesAntiretroviral TherapyAnimalsBiodistributionCd4 AntigensCd4 Lymphocyte CountCommon Terminology Criteria For Adverse EventsDeferoxamineAttenuationHalf-LifeHiv-1Hiv Drug ResistanceHiv InfectionsIgg4ImageImaging CapabilitiesImaging TechnologyImmune ReconstitutionImmunogenicityImmunologistFda ApprovedIn Vivo